Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
Akhil Santhosh, Consultant Medical Oncologist at Baby Memorial Hospitals, shared a post on X about a recent article by Claire N. Harrison et al., published in JCO Oncology Advances, adding:
“Efficacy and Safety Outcomes With Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia: Analysis of Data From the Phase III PERSIST-2 Study, JCO Oncology Advances.”
Title: Efficacy and Safety Outcomes With Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia: Analysis of Data From the Phase III PERSIST-2 Study
Authors: Claire N. Harrison, Prithviraj Bose, Ruben Mesa, Aaron T. Gerds, Stephen T. Oh, Marta Sobas, Valentín Garcia-Gutierrez, Christof Scheid, Alessandro Maria Vannucchi, Jean-Jacques Kiladjian, Vikas Gupta, Abdulraheem Yacoub, David Lavie, Purvi Suthar, Karisse Roman-Torres, Sarah A. Buckley, John Mascarenhas
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?